Ive previously reviewed the GLP-1 family of peptides extensively (here and here) and it seems every week there is a new potential use case, such as we recently saw for migraine and the oneAlzheimers disease that we await with a very high level of anticipation in September from the 2 large trials with semaglutide
Artificial intelligence, including generative models and deep learning, is transforming the design of peptides from scratch
Rather than random fiber deposition, the peptide appears to support organized collagen architecture that more closely resembles healthy fascia
In published preclinical research, 5-Amino-1MQ has been administered across multiple model systems with varying routes documented in the literature (PMID 28121423, PMID 33645410, PMID 35013352, PMID 39067875)
When blood glucose rises after a meal, GLP-1 and GIP both stimulate insulin secretion from pancreatic beta cells
3 Glutathione has also been studied IV for Parkinsons disease